"DOI","paper_doi","paper_title_x","count_atlas_x","Publication_PMID","Publication_link","count_lnpdb","lnp_id","ionizable_lipid","peg_lipid_x","sterol_lipid_x","helper_lipid_x","lipid_molar_ratio_x","particle_size_nm_std","pdi_std","zeta_potential_mv_std","encapsulation_efficiency_percent_std","loading_capacity_std","target_type","nucleic_acid_sequence","peg_lipid_original","ionizable_lipid_original_x","helper_lipid_original","sterol_lipid_original","ionizable_lipid_smiles","peg_lipid_smiles","sterol_lipid_smiles","helper_lipid_smiles","synthesis_info","bioactivity_profile","paper_title_y","paper_authors","paper_journal","paper_year","atlas_row_id","ionizable_lipid_original_y","helper_lipid_y","sterol_lipid_y","peg_lipid_y","lipid_molar_ratio_y","count_atlas_y","matched_id"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,846,"Custom lipid","DMG-PEG2000","cholesterol","DOPE","15:2:25:20",80,0.15,"'-8.5",,"WR:10(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","6Ac1_C12","DOPE","cholesterol","CCCCCCCCCCCCN(C)C(=O)CCCOC(COC(=O)CCCN(C)CCCCCCCCCCCC)(COC(=O)CCCN(C)CCCCCCCCCCCC)OC(=O)CCCN(C)CCCCCCCCCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: 97.9% liver expression; biodistribution_result: Liver (97.9%), Spleen (1.5%), Lung (0.4%), Heart (0.1%), Kidney (0.1%); toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row0","6Ac1_C12","DOPE","cholesterol","DMG-PEG2000","15:2:25:20",1,"Row4"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,847,"Custom lipid","DMG-PEG2000","cholesterol","DOPE","15:2:25:20",85,0.18,"'-8",,"WR:10(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","5Ac1_C12","DOPE","cholesterol",,"CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: liver-targeted expression; biodistribution_result: primarily liver; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row1","5Ac1_C12","DOPE","cholesterol","DMG-PEG2000","15:2:25:20",1,"Row1"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,848,"Custom lipid","DMG-PEG2000",,"DOTAP","60:1.2:0:60",115,0.09,,"~90","WR:20(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","6Ac1_C12","DOTAP",,"CCCCCCCCCCCCN(C)C(=O)CCCOC(COC(=O)CCCN(C)CCCCCCCCCCCC)(COC(=O)CCCN(C)CCCCCCCCCCCC)OC(=O)CCCN(C)CCCCCCCCCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC",,"CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: lung-specific expression; biodistribution_result: primarily lung; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row2","6Ac1_C12","DOTAP",,"DMG-PEG2000","60:1.2:0:60",1,"Row7"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,849,"Custom lipid","DMG-PEG2000","cholesterol","DOTAP","60:1.2:40:60",120,0.08,,"~90","WR:20(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","6Ac1_C12","DOTAP","cholesterol","CCCCCCCCCCCCN(C)C(=O)CCCOC(COC(=O)CCCN(C)CCCCCCCCCCCC)(COC(=O)CCCN(C)CCCCCCCCCCCC)OC(=O)CCCN(C)CCCCCCCCCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: lung-specific expression; biodistribution_result: primarily lung; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row3","6Ac1_C12","DOTAP","cholesterol","DMG-PEG2000","60:1.2:40:60",1,"Row6"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,850,"Custom lipid","DMG-PEG2000","cholesterol","DOPE + DOTAP","15:2:25:20+62",95,0.1,,"~90","WR:20(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","6Ac1_C12","DOPE + DOTAP","cholesterol","CCCCCCCCCCCCN(C)C(=O)CCCOC(COC(=O)CCCN(C)CCCCCCCCCCCC)(COC(=O)CCCN(C)CCCCCCCCCCCC)OC(=O)CCCN(C)CCCCCCCCCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: lung-specific expression; biodistribution_result: primarily lung; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row4","6Ac1_C12","DOPE + DOTAP","cholesterol","DMG-PEG2000","15:2:25:20+62",1,"Row5"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,851,"Custom lipid","DMG-PEG2000",,"DDAB","50:0.2:0:40",75,0.13,"4.8","~90","WR:20(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","6Ac1_C12","DDAB",,"CCCCCCCCCCCCN(C)C(=O)CCCOC(COC(=O)CCCN(C)CCCCCCCCCCCC)(COC(=O)CCCN(C)CCCCCCCCCCCC)OC(=O)CCCN(C)CCCCCCCCCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC",,"CCCCCCCCCC[N+](C)(C)CCCCCCCCCC.[Br-]","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: lung-specific expression; biodistribution_result: primarily lung; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row5","6Ac1_C12","DDAB",,"DMG-PEG2000","50:0.2:0:40",1,"Row3"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,852,"Custom lipid","DMG-PEG2000","cholesterol","DDAB","50:0.2:50:40",92,0.19,"3.5","~90","WR:20(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","6Ac1_C12","DDAB","cholesterol","CCCCCCCCCCCCN(C)C(=O)CCCOC(COC(=O)CCCN(C)CCCCCCCCCCCC)(COC(=O)CCCN(C)CCCCCCCCCCCC)OC(=O)CCCN(C)CCCCCCCCCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCCCC[N+](C)(C)CCCCCCCCCC.[Br-]","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: lung-specific expression; biodistribution_result: primarily lung; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row6","6Ac1_C12","DDAB","cholesterol","DMG-PEG2000","50:0.2:50:40",1,"Row2"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,853,"Custom lipid","DMG-PEG2000","cholesterol","DOPE","15:2:25:20",82,0.16,"'-7.2",,"WR:10(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","2Ac3_C18","DOPE","cholesterol",,"CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: spleen-specific expression; biodistribution_result: primarily spleen; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row7","2Ac3_C18","DOPE","cholesterol","DMG-PEG2000","15:2:25:20",1,"Row0"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,854,"SM-102","DMG-PEG2000","cholesterol","DSPC","50:1.5:38.5:10",85,0.14,"'-6.8",,,"mRNA","firefly_luciferase","DMG-PEG2000","SM_102","DSPC","cholesterol","CCCCCCCCCCCOC(=O)CCCCCN(CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)CCO  ","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v. and i.m.; dose: 0.25 mg/kg mRNA; gene_expression_result: liver expression (i.v.), muscle expression (i.m.); biodistribution_result: primarily liver (i.v.); toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row8","SM_102","DSPC","cholesterol","DMG-PEG2000","50:1.5:38.5:10",1,"Row15"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,855,"SM-102","DMG-PEG2000",,"DOTAP","60:1.2:0:60",110,0.09,,"~90","WR:20(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","SM_102","DOTAP",,"CCCCCCCCCCCOC(=O)CCCCCN(CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)CCO  ","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC",,"CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: lung-specific expression; biodistribution_result: primarily lung; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row9","SM_102","DOTAP",,"DMG-PEG2000","60:1.2:0:60",1,"Row14"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,856,"ALC-0315","ALC-0159","cholesterol","DSPC","46.3:1.6:42.7:9.4",88,0.13,"'-6.5",,,"mRNA","firefly_luciferase","ALC-0159","ALC_0315","DSPC","cholesterol","CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO","CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCN(CCCCCCCCCC(=O)OC)CC(O)COC(=O)CCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v. and i.m.; dose: 0.25 mg/kg mRNA; gene_expression_result: liver expression (i.v.), muscle expression (i.m.); biodistribution_result: primarily liver (i.v.); toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row10","ALC_0315","DSPC","cholesterol","ALC-0159","46.3:1.6:42.7:9.4",1,"Row11"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,857,"ALC-0315","DMG-PEG2000",,"DOTAP","60:1.2:0:60",108,0.09,,"~90","WR:20(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","ALC_0315","DOTAP",,"CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC",,"CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: lung-specific expression; biodistribution_result: primarily lung; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row11","ALC_0315","DOTAP",,"DMG-PEG2000","60:1.2:0:60",1,"Row10"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,858,"DLin-MC3-DMA","DMG-PEG2000","cholesterol","DSPC","50:1.5:38.5:10",92,0.15,"'-7",,,"mRNA","firefly_luciferase","DMG-PEG2000","DLin_MC3_DMA","DSPC","cholesterol","CCCCC/C=C\C/C=C\CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC/C=C\C/C=C\CCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v. and i.m.; dose: 0.25 mg/kg mRNA; gene_expression_result: liver expression (i.v.), muscle expression (i.m.); biodistribution_result: primarily liver (i.v.); toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row12","DLin_MC3_DMA","DSPC","cholesterol","DMG-PEG2000","50:1.5:38.5:10",1,"Row13"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,859,"DLin-MC3-DMA","DMG-PEG2000",,"DOTAP","60:1.2:0:60",112,0.1,,"~90","WR:20(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","DLin_MC3_DMA","DOTAP",,"CCCCC/C=C\C/C=C\CCCCCCCCC(OC(=O)CCCN(C)C)CCCCCCCC/C=C\C/C=C\CCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC",,"CCCCCCCC/C=C\CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: lung-specific expression; biodistribution_result: primarily lung; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row13","DLin_MC3_DMA","DOTAP",,"DMG-PEG2000","60:1.2:0:60",1,"Row12"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,860,"Custom lipid","DMG-PEG2000","cholesterol","DOPE","15:2:25:20",78,0.14,"'-6.2",,"WR:10(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","6Ac1_C8","DOPE","cholesterol",,"CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: liver-targeted expression; biodistribution_result: primarily liver; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row14","6Ac1_C8","DOPE","cholesterol","DMG-PEG2000","15:2:25:20",1,"Row9"
"10.1038/s41467-024-50093-7","https://doi.org/10.1038/s41467-024-50093-7","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation",16,38969646,"https://www.nature.com/articles/s41467-024-50093-7",140,861,"Custom lipid","DMG-PEG2000","cholesterol","DOPE","15:2:25:20",95,0.21,"'-9.5",,"WR:10(wt/wt)[lipid:mRNA]","mRNA","firefly_luciferase","DMG-PEG2000","6Ac1_C18","DOPE","cholesterol",,"CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Ethanol dilution; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: 1:3 (ethanol:aqueous); aqueous_phase_composition: 10 mM sodium citrate buffer, pH 4.0; organic_phase_composition: 100% ethanol; mixing_time_sec: 900; temperature_condition: room temperature; post_processing: dialysis against 1× PBS for 2 h; sterilization: ; storage_buffer: 1× PBS","cell_line: IGROV1; animal_model: C57BL/6 mice; administration_route: i.v.; dose: 0.25 mg/kg mRNA; gene_expression_result: liver-targeted expression; biodistribution_result: primarily liver; toxicity_profile: well tolerated","Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","['Kexin Su', 'Lu Shi', 'Tao Sheng', 'Xinxin Yan', 'Lixin Lin', 'Chaoyang Meng', 'Shiqi Wu', 'Yuxuan Chen', 'Yao Zhang', 'Chaorong Wang', 'Zichuan Wang', 'Junjie Qiu', 'Jiahui Zhao', 'Tengfei Xu', 'Yuan Ping', 'Zhen Gu', 'Shuai Liu']","Nature Communications",2024,"Row15","6Ac1_C18","DOPE","cholesterol","DMG-PEG2000","15:2:25:20",1,"Row8"
